IBIO

iBio, Inc. IBIO

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode IBIO TNXP TRAW JAGX VXRT CODX INO
6M -34.06 % 25.53 % 50.50 % -62.84 % -5.19 % 2.71 % 59.63 %
YTD -67.30 % -32.52 % -65.28 % -92.40 % -53.01 % -47.55 % 41.21 %
1Y -69.57 % 41.27 % -39.92 % -93.43 % -56.37 % -71.29 % -54.91 %
3Y -98.32 % -99.78 % -82.80 % -99.96 % -81.55 % -89.01 % -87.40 %
5Y -99.93 % -100.00 % -97.64 % -99.99 % -95.60 % -97.41 % -98.33 %
10Y -99.98 % -100.00 % -100.00 % -100.00 % -98.53 % -93.48 % -96.21 %
From the beginning -99.98 % -100.00 % -100.00 % -100.00 % -99.71 % -93.48 % -99.64 %

Dividend

Vaxart, Inc.

Inovio Pharmaceuticals, Inc.